Peptide-Coated Nanoparticles for Noninvasive Biomedical Imaging.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Nanoparticles (NPs) offer advantages over free drug molecules in medicine, including improved bioavailability and targeted delivery.
• NPs are utilized for drug delivery, shielding toxic agents, and as contrast agents for medical imaging like MRI.
• Current limitations in cancer therapy and diagnostics necessitate innovative nanoparticle-based solutions.

Purpose of the Study:

• To introduce a novel synthesis method for biodegradable polymeric nanoparticles.
• To functionalize these nanoparticles with short hexapeptides for dual stabilization and cancer cell targeting.
• To evaluate the application of these peptide-coated nanoparticles as optical contrast agents for cancer imaging.

Main Methods:

• Developed a novel synthesis protocol for biodegradable polymeric nanoparticles.
• Coated the nanoparticles with short hexapeptides to impart stability and targeting capabilities.
• Assessed nanoparticle stability in serum and potential for oxidative stress induction in biological settings.
• Demonstrated the use of peptide-coated nanoparticles as optical contrast agents in cancer cell imaging.

Main Results:

• Successfully synthesized biodegradable polymeric nanoparticles coated with short hexapeptides.
• Confirmed that the peptide coating stabilizes the nanoparticles in serum.
• Observed no induction of oxidative stress by the peptide-coated nanoparticles in a biological context.
• Showcased the efficacy of these nanoparticles as optical contrast agents for cancer cell imaging.

Conclusions:

• The novel peptide-coated nanoparticles are stable, non-toxic, and suitable for biomedical applications.
• This pioneering methodology enables dual-functionality of peptides for NP stabilization and cancer cell targeting.
• Peptide-functionalized nanoparticles represent a promising tool for optical imaging in cancer diagnostics.